Skip to main content
Roy Alcalay, MD, Neurology, New York, NY

Roy Nissim Alcalay MD

Hospital/Neurohospitalist


Assistant professor of neurology at the Taub Institute and the program director of the Movement Disorders Fellowship at the Columbia University Medical Center

Join to View Full Profile
  • 710 W 168th StRm 305New York, NY 10032

  • Phone+1 212-305-1303

  • Fax+1 212-305-1304

Dr. Alcalay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
  • Tel Aviv University Sackler
    Tel Aviv University SacklerClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2007 - 2026
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Case Report Corticobasal Syndrome in a Man with Gaucher Disease Type 1: Expansion of the Understanding of the Neurological Spectrum  
    Priya S Kishnani, Jeffrey W Cooney, Roy N Alcalay, Stephanie M DeArmey, ScienceDirect
  • Common and Rare GCH1 Variants Are Associated with Parkinson's Disease  
    Roy N. Alcalay, Stanley Fahn, Cheryl Waters, ScienceDirect

Press Mentions

  • Published Research from the Parkinson’s Foundation Shows Genetic Variants Are More Common in People with Parkinson’s Disease Than Originally Thought
    Published Research from the Parkinson’s Foundation Shows Genetic Variants Are More Common in People with Parkinson’s Disease Than Originally ThoughtJuly 29th, 2024
  • NeuroSense Therapeutics Reports Positive Preliminary Results in Parkinson's Biomarker Study
    NeuroSense Therapeutics Reports Positive Preliminary Results in Parkinson's Biomarker StudyMay 2nd, 2023
  • Study Identifies Pandemic-Related Stressor in Parkinson’s Disease
    Study Identifies Pandemic-Related Stressor in Parkinson’s DiseaseSeptember 23rd, 2021
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: